These limitations thus reveal a great need for future research: new clinical trials should measure postprandial insulin, TG, and markers of oxidative damage and inflammation in response to a broader selection of functional foods with or without physical activity in adults with MetS. This evidence concerns the gene INS and metabolic syndrome.